Literature DB >> 28326304

HIV Diagnosis and Treatment through Advanced Technologies.

Hafiza Fizzah Zulfiqar1, Aneeqa Javed1, Bakht Afroze1, Qurban Ali1, Khadija Akbar1, Tariq Nadeem1, Muhammad Adeel Rana2, Zaheer Ahmad Nazar1, Idrees Ahmad Nasir1, Tayyab Husnain1.   

Abstract

Human immunodeficiency virus (HIV) is the chief contributor to global burden of disease. In 2010, HIV was the fifth leading cause of disability-adjusted life years in people of all ages and leading cause for people aged 30-44 years. It is classified as a member of the family Retroviridae and genus Lentivirus based on the biological, morphological, and genetic properties. It infects different cells of the immune system, such as CD4+ T cells (T-helper cells), dendritic cells, and macrophages. HIV has two subtypes: HIV-1 and HIV-2. Among these strains, HIV-1 is the most virulent and pathogenic. Advanced diagnostic methods are exploring new ways of treatment and contributing in the reduction of HIV cases. The diagnostic techniques like PCR, rapid test, EIA, p24 antigen, and western blot have markedly upgraded the diagnosis of HIV. Antiretroviral therapy and vaccines are promising candidates in providing therapeutic and preventive regimes, respectively. Invention of CRISPR/Cas9 is a breakthrough in the field of HIV disease management.

Entities:  

Keywords:  CRISPR/Cas9; HIV; antiretroviral therapy; lentivirus; macrophages; retoviridae

Year:  2017        PMID: 28326304      PMCID: PMC5339269          DOI: 10.3389/fpubh.2017.00032

Source DB:  PubMed          Journal:  Front Public Health        ISSN: 2296-2565


  115 in total

1.  CXCR4-CCR5: a couple modulating T cell functions.

Authors:  Rita Lucia Contento; Barbara Molon; Cedric Boularan; Tullio Pozzan; Santos Manes; Stefano Marullo; Antonella Viola
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-15       Impact factor: 11.205

2.  HIV eradication--from Berlin to Boston.

Authors:  Paula M Cannon; Donald B Kohn; Hans-Peter Kiem
Journal:  Nat Biotechnol       Date:  2014-04       Impact factor: 54.908

Review 3.  A novel antiretroviral class (fusion inhibitors) in the management of HIV infection. Present features and future perspectives of enfuvirtide (T-20).

Authors:  Roberto Manfredi; Sergio Sabbatani
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

4.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

5.  Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1.

Authors:  Aran F Labrijn; Pascal Poignard; Aarti Raja; Michael B Zwick; Karla Delgado; Michael Franti; James Binley; Veronique Vivona; Christoph Grundner; Chih-Chin Huang; Miro Venturi; Christos J Petropoulos; Terri Wrin; Dimiter S Dimitrov; James Robinson; Peter D Kwong; Richard T Wyatt; Joseph Sodroski; Dennis R Burton
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape.

Authors:  Zhen Wang; Qinghua Pan; Patrick Gendron; Weijun Zhu; Fei Guo; Shan Cen; Mark A Wainberg; Chen Liang
Journal:  Cell Rep       Date:  2016-04-07       Impact factor: 9.423

7.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

8.  CCR5: From Natural Resistance to a New Anti-HIV Strategy.

Authors:  Lucia Lopalco
Journal:  Viruses       Date:  2010-02-05       Impact factor: 5.818

9.  Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.

Authors:  Steven A Yukl; Eli Boritz; Michael Busch; Christopher Bentsen; Tae-Wook Chun; Daniel Douek; Evelyn Eisele; Ashley Haase; Ya-Chi Ho; Gero Hütter; J Shawn Justement; Sheila Keating; Tzong-Hae Lee; Peilin Li; Danielle Murray; Sarah Palmer; Christopher Pilcher; Satish Pillai; Richard W Price; Meghan Rothenberger; Timothy Schacker; Janet Siliciano; Robert Siliciano; Elizabeth Sinclair; Matt Strain; Joseph Wong; Douglas Richman; Steven G Deeks
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

Review 10.  C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection.

Authors:  Fatima Barmania; Michael S Pepper
Journal:  Appl Transl Genom       Date:  2013-05-26
View more
  9 in total

Review 1.  CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity.

Authors:  María José Franco-Tormo; Mireille Salas-Crisostomo; Nuno Barbosa Rocha; Henning Budde; Sérgio Machado; Eric Murillo-Rodríguez
Journal:  J Mol Neurosci       Date:  2018-05-07       Impact factor: 3.444

2.  An immunoregulatory role of dendritic cell-derived exosomes versus HIV-1 infection: take it easy but be warned.

Authors:  Dimitry A Chistiakov; Andrey V Grechko; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Ann Transl Med       Date:  2017-09

Review 3.  Protein purification and analysis: next generation Western blotting techniques.

Authors:  Manish Mishra; Shuchita Tiwari; Aldrin V Gomes
Journal:  Expert Rev Proteomics       Date:  2017-10-13       Impact factor: 3.940

Review 4.  Recent advances in carbon quantum dots for virus detection, as well as inhibition and treatment of viral infection.

Authors:  Yuxiang Xue; Chenchen Liu; Gavin Andrews; Jinyan Wang; Yi Ge
Journal:  Nano Converg       Date:  2022-04-02

Review 5.  Finding a chink in the armor: Update, limitations, and challenges toward successful antivirals against flaviviruses.

Authors:  Thamil Vaani Komarasamy; Nur Amelia Azreen Adnan; William James; Vinod Rmt Balasubramaniam
Journal:  PLoS Negl Trop Dis       Date:  2022-04-28

Review 6.  Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?

Authors:  V Kalidasan; Kumitaa Theva Das
Journal:  Front Microbiol       Date:  2020-01-31       Impact factor: 5.640

7.  Effects of the killer immunoglobulin-like receptor (KIR) polymorphisms on HIV acquisition: A meta-analysis.

Authors:  Suwit Chaisri; Noel Pabalan; Sompong Tabunhan; Phuntila Tharabenjasin; Nipaporn Sankuntaw; Chanvit Leelayuwat
Journal:  PLoS One       Date:  2019-12-02       Impact factor: 3.240

8.  Towards the De Novo Design of HIV-1 Protease Inhibitors Based on Natural Products.

Authors:  Ana L Chávez-Hernández; K Eurídice Juárez-Mercado; Fernanda I Saldívar-González; José L Medina-Franco
Journal:  Biomolecules       Date:  2021-12-01

Review 9.  Novel Antiretroviral Therapeutic Strategies for HIV.

Authors:  Rita F Cunha; Sandra Simões; Manuela Carvalheiro; José M Azevedo Pereira; Quirina Costa; Andreia Ascenso
Journal:  Molecules       Date:  2021-08-31       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.